Geode Capital Management »

Nkgen Biotech shares owned by Geode Capital Management

Quarter-by-quarter ownership of Nkgen Biotech (NKGN) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Nkgen Biotech

Tip: Access up to 7 years of quarterly data

All positions including Nkgen Biotech held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkgen Biotech by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $101k 53k 1.89

More positions owned by Geode Capital Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Visa Inc-class A Shares Com Cl A (V)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Geode Capital Management

Top funds holding Nkgen Biotech

Meteora Capital
Polar Securities
University Of Chicago
Vanguard Group
Geode Capital Management
Susquehanna International
Sequoia Financial Advisors
Northern Trust
UBS Group
Towneley Capital Management, Inc / DE
Tower Research Capital
Federation des caisses Desjardins du Quebec
Wells Fargo & Company

View all funds holding Nkgen Biotech